Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study

Abstract Objectives To determine prognostic factors for survival in ovarian cancer patients treated with intraperitoneal (IP) chemotherapy using ancillary data from cooperative group clinical trials. Methods Data were collected from 428 patients with stage III ovarian cancer who underwent optimal su...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 2013-07, Vol.130 (1), p.12-18
Hauptverfasser:	Landrum, Lisa M, Java, James, Mathews, Cara A, Lanneau, Grainger S, Copeland, Larry J, Armstrong, Deborah K, Walker, Joan L
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Carboplatin - administration & dosage Carcinoma, Ovarian Epithelial Cisplatin - administration & dosage Cyclophosphamide - administration & dosage Disease-Free Survival Epithelial ovarian cancer Female Hematology, Oncology and Palliative Medicine Humans Infusions, Parenteral Intraperitoneal chemotherapy Lymphatic Metastasis Middle Aged Multicenter Studies as Topic Multivariate Analysis Neoplasm Staging Neoplasm, Residual Neoplasms, Glandular and Epithelial - drug therapy Neoplasms, Glandular and Epithelial - pathology Neoplasms, Glandular and Epithelial - surgery Obstetrics and Gynecology Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Ovarian Neoplasms - surgery Paclitaxel - administration & dosage Prognosis Randomized Controlled Trials as Topic Retrospective Studies Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!